Protocol·One
Editorial reference, not medical advice. This quiz returns specific peptide names, stack recommendations, and dose-titration links. Some of what's referenced is for compounds the FDA has not approved at the dose level discussed. Some is off-label use of approved drugs. Some is research-grade material with thin Western evidence. None of it replaces a real prescriber. Read for context. Don't self-prescribe.

Tools · Master Quiz

Which peptide is right for you?

Eleven questions. Across the full 17-peptide directory. About what you are trying to fix, your numbers, your history, your budget, and your risk tolerance. We'll surface the most likely fit at the end. None of it replaces a real prescriber.

Master Quiz

Question 1 of 11

What's the primary thing you're trying to fix or improve?

Pick the one closest to why you're here. There's no wrong answer.

How old are you?

Risk and benefit shift with age. The recovery, GH-axis, and longevity stacks are calibrated to the over-35 reader.

Sex assigned at birth?

Matters for FDA labels. Pregnancy contraindications, PCOS-related logic, HSDD (hypoactive sexual desire disorder) labeling, and post-menopausal flags depend on this answer.

What have you already tried for this goal?

Pick all that apply. Honest signal helps the recommendation. There is no wrong answer.

How active are you?

Activity level changes which stacks make sense. Athlete-level training opens recovery and GH-axis paths that don't apply to a sedentary reader.

Any of these in your medical history?

Pick all that apply. These are the items GLP-1 and peptide labels flag, plus a few mechanism-based cautions. If none apply, pick the last one.

Comfort with injection?

Most peptide protocols are subQ (under-the-skin) shots. Some are oral. Some are topical. Some are nasal. This matters for which stack fits.

What's your budget posture?

Branded GLP-1s without coverage run roughly $1,000 a month. Compounded peptides through telehealth typically run $200 to $500. Cash-pay paths exist for most stacks.

Risk tolerance for the regulatory landscape?

The peptide world is split between FDA-approved branded drugs, off-label use of approved drugs, compounded versions in a legal gray zone, and overseas research-grade material.

What's your reading depth posture?

Some readers want a clear next step. Some want the evidence first. Some want both, plus the user-reported reality.

Anything else worth flagging?

Optional. Pick all that apply. These shift the recommendation toward stacks that handle the specific situation. If none apply, pick the last one.

How this quiz works

This is editorial reference, not medical advice. It runs entirely in your browser. Your answers never leave the page. We don't save your age, history, or anything else anywhere.

The scoring uses public information from FDA drug labels, named clinical trials (SURMOUNT, STEP, SELECT, SURMOUNT-5, RECONNECT, CARS, CAPTAIN), and standard prescriber screening criteria. It is a starting point for a real conversation with a real doctor. It is not a replacement.

Always with a doctor. None of this replaces a real prescriber.

Where to go next

Read the foundations:

Browse the catalog:

Already know the goal? Take the focused tool:

Last reviewed · 2026·05·08 · Editorial tool, updated as the field moves